OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2025-12-31-accounts

C01377.0002/AIG/EBR/TZH

THE CHILDREN'S HEART DISEASE TRUST

Accounts

For The Year Ended

31 December 2025

Registered Scottish Charity No: SC016507

C01377.0002 Children's Heart Disease 2025 accounts(1012360363.1)

THE CHILDREN'S HEART DISEASE TRUST

Contents

Page

THE CHILDREN'S HEART DISEASE TRUST

General Information and Report of the Trustees

For Year Ended 31 December 2025

Reference and Administrative Information

Charity Number: SC016507
Address of Principal Shepherd and Wedderburn LLP
Office: 9 Haymarket Square
Edinburgh EH3 8FY
Trustees: Janet Burns
Muhammad Walayat
Mairi Macinnes
Bankers: Bank of Scotland
33 Old Broad Street
London
PO Box 1000 BX2 1LB
Solicitors and Shepherd and Wedderburn LLP
Administrators: 9 Haymarket Square
Edinburgh EH3 8FY
Independent Examiner: Neil McNab
40 Hawkhill
Edinburgh EH7 6LB
Investment Manager: Rathbones Investment Management Limited
Quartermile One
3rd Floor
15 Lauriston Place
Edinburgh EH3 9EN
Structure, Governance and Management
Overview: The trust was created by Declaration of Trust dated 18 December 1980 and registered in
the Books of Council and Session on 24 December 1980.
Charitable Status: The trust is a registered Scottish charity. As such, the trustees must ensure the
circumstances and operations of the trust continue to meet the charity test and the
governors are required to comply with their statutory duty to supply information to the
Scottish Charity Regulator, the Office of the Scottish Charity Regulator (OSCR).
Trustee Tenure: On the basis of trustee appointment, there is no predefined period. The power to appoint
new trustees is reserved to the trustees in office. The induction process involves
awareness of a trustee's responsibilities, the governing document, administration
procedures, and the history of the charity. A new trustee should receive a copy of the
previous year's account and also an extract from the Charities and Trustee Investment
(Scotland) Act 2005 relating to charity trustees. Shepherd and Wedderburn LLP is
responsible for the induction of new trustees.

Page 1

THE CHILDREN'S HEART DISEASE TRUST

General Information and Report of the Trustees (Contd)

For Year Ended 31 December 2025 (Contd)

Objectives of Trust

Trust Objectives: The objects of the trust are the furtherance in any part of the world of investigation, study, observation, diagnosis, treatment, amelioration, care of and research into cardiological disorders of children and disorders of a like nature.

Grant Making Policy: The trustees have a policy of making awards to medical professionals they feel require most support and whose field of expertise or studies fall within the spectrum of the objects of the trust.

Financial Review

Overview: The period closed with unrestricted funds of £503,612.78 (2024; £428,447.45). Investment income and bank interest amounted to £16,377.64 (2024; £16,295.53). In addition to this £42,328.53 (2024; £nil) was received from two estates. During the accounting period the trustees made charitable payments of £3,668.36 (2024; £42,420.36 ). Total resources expended amounted to £16,547.75 (2024; £56,366.18). The trustees report a surplus for the period of £55,965.33 (2024; £4,356.04 deficit).

The trustees note the performance of the trust portfolio over the period. Overall investment gains for the period were £33,006.91 (2024; £5,714.61 gains) which reflects the general market and economic sentiment over the year. The trustees will continue to monitor the performance of the trust portfolio and take action as necessary.

Investment Policy: In accordance with the Declaration of Trust and statutory provision, the trustees have the power to invest in such stocks, shares and investments in the United Kingdom or overseas as they in their sole discretion think fit. During the accounting period the operations of Investec Wealth & Investment Limited were formally transferred to Rathbones Investment Management Limited who manage the trust portfolio on a discretionary basis.

The trustees' investment policy is geared towards a balanced return between capital and income from a low to medium risk perspective and this is reviewed on a regular basis. The portfolio performance is measured against a bespoke benchmark tailored to the investment policy.

Reserves Policy: It is the policy of the trustees to distribute the income of the trust in the form of awards for the benefit of medical practitioners. The trustees can also encroach on the trust capital in furtherance of the trust objectives. The trustees are satisfied the unrestricted funds of £503,612.78 as at 31 December 2025 is adequate to fulfil the charity's obligations.

Charitable Activities Details of the charitable payments made during the period are set out in note 5 to the During Year: accounts.

Risk Review

Risk Management The trustees have assessed the major risks to which the charity is exposed, in particular Policy: those related to the operations and finances of the trust and are satisfied systems are in place to mitigate exposure to the major risks.

Related Parties: No remuneration or expenses were paid to any trustee (2024; £nil).

Page 2

THE CHILDREN'S HEART DISEASE TRUST

General Information and Report of the Trustees (Contd)

For Year Ended 31 December 2025 (Contd)

Plans for the future — The trustees do not anticipate any material changes in the operations of the charity in the forthcoming year. A process is underway to make a minor change to the name of the charity. The trustees will continue to fund the sponsorship scheme for overseas cardiologists and cardiac surgeons which is run by the BCCA, subject to a suitable candidate being identified.

Approved by the trustees and signed on their behalf:

Signed: Oe”... TT eee ETO _ Muhammad Walayat, trustee Date sgnansiaghe esa soe fal BR PNat Nera) 3 de, ais sasiaaide Sei daa rnen GamenmameCE sakes /

Page 3

THE CHILDREN'S HEART DISEASE TRUST

Statement of Receipts and Payments for the year ended 31 December 2025

Note
Receipts
Incoming resources from generated funds:
Donations and legacies
2
Investment income payable during year
3
Bank interest
3
Total incoming resources
Payments
Costs of generating funds:
Investment management costs
4
Charitable activities:
Charitable payments
5
Support costs
6
Governance costs
7
Total resources expended
Net incoming/(outgoing) resources before asset and
investment movements, and transfers
Asset and investment movements
Proceeds from sale of investments
8
Purchase of investments
8
Net receipts/(payments) after asset and investment movements
Transfers to / (from) funds
Surplus/(deficit) for year
2025
£
42,328.53
15,696.55
681.09
58,706.17
(3,429.39)
(3,668.36)
(4,650.00)
(4,800.00)
(16,547.75)
42,158.42
119,926.09
(106,119.18)
55,965.33
-
55,965.33
2024
£
-
15,980.59
314.94
16,295.53
(4,168.70)
(42,420.36)
(4,813.56)
(4,963.56)
(56,366.18)
(40,070.65)
44,549.93
(8,835.32)
(4,356.04)
-
(4,356.04)

All movements relate to unrestricted funds

The notes on pages 6 to 9 form part of these accounts

Page 4

THE CHILDREN'S HEART DISEASE TRUST

Statement of Balances as at 31 December 2025

Note 2025 2024
£ £
Funds reconciliation
Cash at bank and in hand 31/12/2024 10,053.45 14,409.49
Surplus/(deficit) foryear 55,965.33 (4,356.04)
Cash at bank and in hand 31/12/2025 66,018.78 10,053.45
Represented by
Bank accounts 9 63,812.11 7,797.05
Debtors 10 2,206.67 2,256.40
66,018.78 10,053.45
Other Assets
Investments at market value 8 437,594.00 418,394.00
Liabilities
2025 2024
7a £
Shepherd and Wedderburn LLP, fee 11 - 2,640.00
Neil McNab, Independent Examiner fee 11 150.00 150.00
150.00 2,790.00

All funds are unrestricted

The notes on pages 6 to 9 form part of these accounts

Approved by the trustees and signed on their behalf: a

==> picture [404 x 72] intentionally omitted <==

----- Start of picture text -----
Signed: Naresh atu Passteepeiccho aa deedede da eleeton ston Reuen acco eae nneaietra ucesten Maslantintete eam ient
Muhammad Walayat, trustee
Date sn
----- End of picture text -----

Date

Page 5

THE CHILDREN'S HEART DISEASE TRUST

Notes To The Accounts

For The Year Ended 31 December 2025

1 Accounting Policies

These accounts have been prepared on a receipts and payments basis in accordance with the Charities and Trustees Investment Act (Scotland) 2005 and the Charities Accounts (Scotland) Regulations 2006 (as amended).

Incoming Resources

All incoming resources are included in the Statement of Receipts and Payments when the trust is entitled to the income and the amount can be quantified with reasonable accuracy. The following specific policies are applied to particular categories of income:

Resources Expended

Expenditure is recognised on a receipts and payments basis. Expenditure includes any VAT which cannot be fully recovered and is reported as part of the expenditure to which it relates:

Investments

Investments are included at market value at the year end, with investment sales and purchases reflected through the Statement of Receipts and Payments.

2 Donations and Legacies

Margaret Henderson estate
Elizabeth Posnett estate
2025
2024
9,941.52
£
-
£
32,387.01
-
42,328.53
£
-
£

Page 6

THE CHILDREN'S HEART DISEASE TRUST

Notes To The Accounts (Contd)

For The Year Ended 31 December 2025 (Contd)

3 Investment Income

UK dividends
UK unit trust dividends
UK interest
UK unit trust interest
UK property income distributions
Overseas dividends
Overseas interest
Bank interest
4
Costs of Generating Funds
Investment Management Costs:
Investec Wealth & Investment Limited, fees to 31/12/2025 (inc VAT)
Rathbones Investment Management Limited, fees to 31/12/2025 (inc VAT)
5
Charitable Payments
Dzung Memorial Lecture:
Mahmoud Montasser (BCCA 2025)
Yogan Singh (BCCA 2024)
Hannah Barr
Charitable payments 2024 (awards to two cardiac health specialists)
6
Support Costs
Shepherd and Wedderburn LLP, fees to 31/12/2025 (inc VAT)
7
Governance Costs
Shepherd and Wedderburn LLP, fees to 31/12/2025 (inc VAT)
Independent Examiner's fee:
Neil McNab, fee relative to the 2024 account
2025
2,264.44
£
2,981.78
1,731.17
1,946.45
1,512.42
1,129.06
4,131.23
681.09
16,377.64
£
2025
1,329.66
£
2,099.73
3,429.39
£
2025
4,650.00
£
2025
4,650.00
£
150.00
4,800.00
£
2024
2,783.88
£
2,868.14
1,160.04
2,336.60
1,660.69
1,248.03
3,923.21
314.94
16,295.53
£
2024
4,168.70
£
-
4,168.70
£
2025
846.45
£
1,000.00
1,821.91
3,668.36
£
42,420.36
£
2024
4,813.56
£
2024
4,813.56
£
150.00
4,963.56
£

Page 7

THE CHILDREN'S HEART DISEASE TRUST

Notes To The Accounts (Contd)

For The Year Ended 31 December 2025 (Contd)

8 Investments

Market value at 31 December 2024
Additions during the year
Disposals during the year
Realised gains on investments
Unrealised gains on investments
Market value at 31 December 2025
2025
2024
418,394.00
£
448,394.00
£
106,119.18
8,835.32
(119,926.09)
(44,549.93)
5,975.31
2,119.85
27,031.60
3,594.76
437,594.00
£
418,394.00
£

UK domiciled securities are held on the trust’s behalf by Rathbones Investment Management Limited and registered in their nominee name. Overseas domiciled securities are held on the trust's behalf by a subcustodian appointed by Rathbones Investment Management Limited and registered in the name of the subcustodian's nominee. As at 31 December 2025 the market value of the UK domiciled securities was £281,111.00 and the market value of the overseas domiciled securities was £156,483.00.

Investments with a current market value in excess of 5% of total:

UK (Govt of)
£25,300 1.25% treasury stock 22/07/2027
Breakdown of Closing Bank Balances
Investec Wealth & Investment Limited:
Capital account
Income account
Rathbones Investment Management Limited
Capital account
Income account
Shepherd and Wedderburn LLP:
Current account
Deposit account
Debtors
Abrdn Global Index Linked Bond Fund interest payment
Investec Wealth & Investment Limited remittance
Rathbones Investment Management Limited remittance
Royal London Sterling Credit Fund interest payment
2025
-
£
-
12,481.15
636.22
1,210.17
49,484.57
63,812.11
£
2025
69.50
£
-
1,926.78
210.39
2,206.67
£
2025
24,526.00
£
2024
2,046.13
£
-
-
-
-
5,750.92
7,797.05
£
2024
-
£
2,256.40
-
-
2,256.40
£

9 Breakdown of Closing Bank Balances

10 Debtors

Page 8

THE CHILDREN'S HEART DISEASE TRUST

Notes To The Accounts (Contd)

For The Year Ended 31 December 2025 (Contd)

11 Liabilities

Shepherd and Wedderburn LLP, fee (inc VAT)
Independent Examiner's fee:
Neil McNab, fee relative to the 2025 account
2025
2024
-
£
2,640.00
£
150.00
150.00
150.00
£
2,790.00
£

12 Related Party Transactions

No remuneration or expenses were paid to any trustee (2024; £nil).

Page 9

THE CHILDREN'S HEART DISEASE TRUST

Independent Examiner's Report To The Trustees

I report on the accounts of the charity for the year ended 31 December 2025, set out on pages 4 to 8.

Respective responsibilities of the Trustees and the Independent Examiner

As described in the Trustee's Report, the trustees are responsible for the preparation of the financial statements in accordance with the terms of the Charities and Trustees Investment (Scotland) Act 2005 and the Charities Accounts (Scotland) Regulations 2006 (as amended). The charity's trustees consider that the audit requirements of Regulation 10 (1) (d) of the Accounts Regulations does not apply. It is my responsibility to examine the financial statements as required under 44 (1) (c) of the Act and to state whether particular matters have come to my attention.

Basis of Independent Examiner's Report

My examination was carried out in accordance with Regulation 11 of The Charities Accounts (Scotland) Regulations 2006 (as amended). An examination includes a review of the accounting records kept by the charity and a comparison of the accounts presented with those records. It also includes consideration of any unusual items or disclosures in the accounts, and seeking explanations from the Trustees concerning any such matters. The procedures undertaken do not provide all the evidence that would be required in an audit, and consequently I do not express an audit opinion on the view given by the accounts.

Independent Examiner's Statement

In the course of my examination, no other matter has come to my attention:

  1. which gives me reasonable cause to believe that in any material respect the requirements;

  2. to keep accounting records in accordance with Section 44 (1) (a) of the 2005 Act and Regulation 4 of the 2006 Accounts Regulations (as amended); and

  3. to prepare accounts which accord with the accounting records and comply with Regulation 9 of the 2006 Accounts Regulations (as amended);

have not been met; or

  1. to which, in my opinion, attention should be drawn in order to enable a proper understanding of the accounts to be reached.

Name: Neil McNab Relevant professional qualification/professional body; Society of Law Accountants in Scotland

Address: 40 Hawkhill Edinburgh EH7 6LB

Date:

Page 10

9 Haymarket Square Edinburgh EH3 8FY DX:551970 Edinburgh 53 T +44 (0)131 228 9900 F +44 (0)131 228 1222

shepwedd.com

Shepherd and Wedderburn LLP is a limited liability partnership incorporated in Scotland with number SO300895. Registered office and principal place of business: 9 Haymarket Square, Edinburgh EH3 8FY. The term partner in relation to Shepherd and Wedderburn LLP is used to refer to a member of Shepherd and Wedderburn LLP. A list of the names of the members is available for inspection at the principal place of business. All correspondence signed by a named individual is signed for and on behalf of Shepherd and Wedderburn LLP. Details of the country or jurisdiction in which the firm’s lawyers are professionally qualified are set out at shepwedd.com/legal-notices. Shepherd and Wedderburn LLP is regulated by the Law Society of Scotland and is authorised and regulated by the Solicitors Regulation Authority (with number 447895).